Abstract:Diabetic kidney disease (DKD) is the principal culprit behind chronic kidney disease (CKD), ultimately developing end-stage renal disease (ESRD) and necessitating costly dialysis or kidney transplantation. The limited therapeutic efficiency among individuals with DKD is a result of our finite understanding of its pathogenesis. DKD is the result of complex interactions between various factors. Oxidative stress is a fundamental factor that can establish a link between hyperglycemia and the vascular complications frequently encountered in diabetes, particularly DKD. It is crucial to recognize the essential and integral role of oxidative stress in the development of diabetic vascular complications, particularly DKD. Hyperglycemia is the primary culprit that can trigger an upsurge in the production of reactive oxygen species (ROS), ultimately sparking oxidative stress. The main endogenous sources of ROS include mitochondrial ROS production, NADPH oxidases (Nox), uncoupled endothelial nitric oxide synthase (eNOS), xanthine oxidase (XO), cytochrome P450 (CYP450), and lipoxygenase. Under persistent high glucose levels, immune cells, the complement system, advanced glycation end products (AGEs), protein kinase C (PKC), polyol pathway, and the hexosamine pathway are activated. Consequently, the oxidant–antioxidant balance within the body is disrupted, which triggers a series of reactions in various downstream pathways, including phosphoinositide 3-kinase/protein kinase B (PI3K/Akt), transforming growth factor beta/p38-mitogen-activated protein kinase (TGF-β/p38-MAPK), nuclear factor kappa B (NF-κB), adenosine monophosphate-activated protein kinase (AMPK), and the Janus kinase/signal transducer and activator of transcription (JAK/STAT) signaling. The disease might persist even if strict glucose control is achieved, which can be attributed to epigenetic modifications. The treatment of DKD remains an unresolved issue. Therefore, reducing ROS is an intriguing therapeutic target. The clinical trials have shown that bardoxolone methyl, a nuclear factor erythroid 2-related factor 2 (Nrf2) activator, blood glucose-lowering drugs, such as sodium-glucose cotransporter 2 inhibitors, and glucagon-like peptide-1 receptor agonists can effectively slow down the progression of DKD by reducing oxidative stress. Other antioxidants, including vitamins, lipoic acid, Nox inhibitors, epigenetic regulators, and complement inhibitors, present a promising therapeutic option for the treatment of DKD. In this review, we conduct a thorough assessment of both preclinical studies and current findings from clinical studies that focus on targeted interventions aimed at manipulating these pathways. We aim to provide a comprehensive overview of the current state of research in this area and identify key areas for future exploration.

Effects of diabetes on oxidative and nitrosative stress in kidney mitochondria from aged rats

Adaptive Changes in Renal Mitochondrial Redox Status in Diabetic Nephropathy.

Increased Oxidative and Nitrative Stress Accelerates Aging of the Retinal Vasculature in the Diabetic Retina

Study on the Role of Oxidative Stress in the Kidneys of Diabetic Rats

Oxidative Stress, Apoptosis, and Mitochondrial Function in Diabetic Nephropathy

Oxidative and nitrosative stress in brain mitochondria of diabetic rats

Oxidative Stress in Diabetic Nephropathy with Early Chronic Kidney Disease

Oxidative stress as a culprit in diabetic kidney disease

Peroxynitrite and protein nitration in the pathogenesis of diabetic peripheral neuropathy

Mitochondrial Function Is Not Affected by Renal Morphological Changes in Diabetic Goto-Kakizaki Rat

Mitochondrial dysfunction in brain cortex mitochondria of STZ-diabetic rats: effect of l-Arginine

Effects of redox interference on the pancreatic mitochondria and the abnormal blood glucose

Biomarkers of Oxidative Stress in Diabetes Mellitus with Diabetic Nephropathy Complications

Oxidative Stress: A Culprit in the Progression of Diabetic Kidney Disease

Oxidative Stress and NRF2/KEAP1/ARE Pathway in Diabetic Kidney Disease (DKD): New Perspectives

Effects of Ecdysterone on Oxidative Stress on Nephropathy in STZ-induced Diabetic Rats

NAD metabolism modulates inflammation and mitochondria function in diabetic kidney disease

The Prospective Ameliorative Role of Zinc Oxide Nanoparticles in STZ-Induced Diabetic Nephropathy in Rats: Mechanistic Targeting of Autophagy and Regulating Nrf2/TXNIP/NLRP3 Inflammasome Signaling

AGE/RAGE in diabetic kidney disease and ageing kidney

Anti-Oxidative Therapy in Diabetic Nephropathy.

Oxidative Stress Markers in Chronic Kidney Disease with Emphasis on Diabetic Nephropathy